Skip to main content

Table 8 Outcomes predicted by models for one birth cohort in Sear-region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

 

POLYMODa

Roxanne

CoRoVa

Undiscounted cases

   

   Mild

216,205

276,861

299,907

   Moderate

114,255

159,129

127,020

   Severe

11,887

22,086

12,325

   Nosocomial

3,923

4,748

6,309

   Deaths

1,486

2,752

2,366

   Outpatient

126,142

159,129

127,020

   Inpatient (comm. acq.)

11,887

22,086

12,325

Discounted savings

   

   Outpatient

$1,135,274

$1,391,130

$1,852,744

   Inpatient

$2,208,959

$2,975,397

$1,712,409

   Indirect

$1,267,227

$1,213,598

$948,564

Discounted net costsb (*1000)

$15,424

$ 19,969-39,083

$ 20,545-39,423

Discounted QALYs

   

   Mortality

41,822

75,969

65,244

   Morbidity

1,261

1,731

1,462

  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective and range given for previous upper and lower vaccine prices if appropriate.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us